SEC Form 4 · accession 0000899243-17-016391
Ocugen, Inc. · OCGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David N Gill
Director
Period of report
Jun 13, 2017
Accepted (ET)
Jun 14, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.70 | Jun 13, 2017 | A | 25,000 | A | — | Jun 12, 2027 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests and becomes exercisable with respect to 8.33% of the option shares for each one-month period following June 13, 2017.